Shweta Arora
Family Medicine · Washington, PANPI 1841447000
Payments from drug & device makers
Across 223 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$578
- AbbVie$453
- Pfizer$430
- Lilly USA, LLC$335
- GSK$296
- Amgen$171
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,914100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 36 | $578 |
| AbbVie | 29 | $453 |
| Pfizer | 24 | $430 |
| Lilly USA, LLC | 21 | $335 |
| GSK | 17 | $296 |
| Amgen(2 entities) | 11 | $171 |
| Abbott | 10 | $162 |
| Dexcom, Inc. | 9 | $148 |
| Shield Therapeutics Inc | 2 | $112 |
| AstraZeneca | 7 | $105 |
| Novartis | 4 | $89 |
| Exact Sciences | 4 | $88 |
| Aimmune Therapeutics, Inc. | 5 | $86 |
| Sanofi Pasteur Inc. | 3 | $84 |
| Boehringer Ingelheim | 4 | $72 |
| Astellas Pharma US Inc | 3 | $67 |
| Insulet Corporation | 3 | $59 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
| Medtronic | 2 | $43 |
| Merck | 3 | $43 |
| Bayer | 2 | $36 |
| Vertex | 1 | $33 |
| Alkermes, Inc. | 2 | $33 |
| Tonix Medicines, Inc. | 1 | $31 |
| Corcept Therapeutics | 1 | $26 |
| Edwards Lifesciences | 1 | $25 |
| CSL Behring | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Axonics, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Noven Therapeutics, LLC | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,923 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 136 | $121,294 |
| MounjaroTirzepatide | 103 | $105,722 |
| OzempicSemaglutide | 109 | $100,464 |
| JanuviaSitagliptin Phosphate | 47 | $45,649 |
| TradjentaLinagliptin | 36 | $29,571 |
| Repatha SureclickEvolocumab | 38 | $24,233 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $22,613 |
| FarxigaDapagliflozin Propanediol | 20 | $20,827 |
| EliquisApixaban | 23 | $14,804 |
| TrulicityDulaglutide | 14 | $13,052 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $10,217 |
| Repatha SyringeEvolocumab | 12 | $8,956 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 74 | $8,745 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $7,008 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $5,721 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat | $72 | $155,880183 claims |
| Lilly USA, LLCMounjaro, Trulicity | $335 | $118,774117 claims |
| Novo NordiskOzempic | $578 | $100,464109 claims |
| MerckJanuvia | $43 | $45,64947 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $296 | $29,62143 claims |
| AstraZenecaFarxiga, Symbicort | $105 | $23,77633 claims |
| PfizerEliquis | $430 | $14,80423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Washington
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.